Skip to main content
Glama

Apology

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. v1 supports \"company\"."New value: +"Entity type: \"company\" or \"drug\"."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "drug"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker, CIK, or company name (e.g., \"AAPL\", \"0000320193\", \"Apple\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."
  3. Added

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint=false, and the description adds substantial behavior: graceful degradation when GLEIF/OpenFIGI are unavailable, `unresolved` field for missing identifiers, multiple internal endpoints, and precise handling of bond issuer names. No contradictions.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but well-organized: it opens with use cases, then breaks down supported types, then explains edge cases. Every sentence adds unique value—no fluff. It's denser than ideal but the complexity of the tool justifies the length. Front-loaded with the key action ('Use FIRST').

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity—two entity types, multiple identifier sources, nested logic for bonds and ISINs—the description covers all necessary details an agent needs to call it correctly. It explains return semantics (`unresolved`, `figi_candidates`), and even though there's no output schema, the description tells what to expect. No missing guidance.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100% for both parameters, yet the description adds critical semantic nuance beyond the schema. The `value` parameter gets extensive guidance: exact formats for tickers/CIKs/ISINs, the instruction to pass only the entity name (not full noun phrases) for bonds, and examples. This exceeds the schema's minimal descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool resolves names to canonical identifiers, lists example queries, and explicitly says 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It differentiates from siblings by positioning itself as the first tool to use when you have a name but need an ID, which is distinct and memorable.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives an explicit directive: 'Use FIRST whenever you have a name but need an ID.' It also lists supported types and describes when to use each (company vs. drug), and notes it replaces 2-3 manual lookups. No ambiguity about when to invoke this tool.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Apology toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are near-duplicates with beta explicitly identical to the stable version, causing potential misselection. ai_visibility_check and scan_competitor_ai_presence overlap heavily, and resolve_entity/discover_tools/ask_pipeworx all serve lookup purposes. Many tools are distinct, but the boundaries around the core query tools are blurry.

Naming Consistency2/5

Naming is inconsistent: mostly snake_case but mixed verb styles (ask_pipeworx vs pipeworx_feedback vs resolve_entity), brand prefixes applied irregularly, and no uniform convention (e.g., subscribe/unsubscribe/list_subscriptions vs forget/remember/recall vs polymarket_arbitrage/edges/edge_tracker). Some names are descriptive, but the set lacks a predictable pattern.

Tool Count2/5

32 tools is above the 25 threshold for a heavy surface, and the server mixes unrelated domains (data lookup, prediction markets, memory, subscriptions, AI visibility, apology generation). While a large data platform could justify many tools, the random inclusions (apology_generate, generate_llms_txt, scan_dependency) suggest a lack of scoping. Several tools could be consolidated without loss.

Completeness4/5

For the dominant data-research/prediction-market domain, coverage is strong: lookup, grounded verification, research, entity resolution, comparison, arbitrage scanning, fill risk, subscriptions, memory, and discovery are all present. Minor gaps exist (no direct account management beyond subscriptions, no tool to modify stored memories), but agents can mostly achieve their goals. The stray non-domain tools do not hurt completeness of the core platform.

Resources